85 related articles for article (PubMed ID: 17434171)
1. The effect of high-dose aspirin pre-treatment on the incidence of myonecrosis following elective coronary stenting.
Gulec S; Ozdol C; Vurgun K; Selcuk T; Turhan S; Duzen V; Temizhan A; Ozturk S; Ozdemir AO; Erol C
Atherosclerosis; 2008 Mar; 197(1):171-6. PubMed ID: 17434171
[TBL] [Abstract][Full Text] [Related]
2. Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis.
Claeys MJ; Van der Planken MG; Bosmans JM; Michiels JJ; Vertessen F; Van Der Goten P; Wuyts FL; Vrints CJ
Eur Heart J; 2005 Mar; 26(6):567-75. PubMed ID: 15618034
[TBL] [Abstract][Full Text] [Related]
3. [Study on the relationship between aspirin resistance and incidence of myonecrosis after non-emergent percutaneous coronary intervention].
Zhang Y; Liang J; Zhou YJ; Yuan H; Zhang YZ; Dong L
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Aug; 33(8):695-9. PubMed ID: 16188050
[TBL] [Abstract][Full Text] [Related]
4. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment.
Chen WH; Lee PY; Ng W; Tse HF; Lau CP
J Am Coll Cardiol; 2004 Mar; 43(6):1122-6. PubMed ID: 15028378
[TBL] [Abstract][Full Text] [Related]
5. A study comparing the incidence and predictors of creatine kinase MB and troponin T release after coronary angioplasty. Does Clopidogrel preloading reduce myocardial necrosis following elective percutaneous coronary intervention?
Moore RK; Lowe R; Grayson AD; Morris JL; Perry RA; Stables RH
Int J Cardiol; 2007 Mar; 116(1):93-7. PubMed ID: 16870281
[TBL] [Abstract][Full Text] [Related]
6. Use of statins prior to percutaneous coronary intervention reduces myonecrosis and improves clinical outcome.
Chang SM; Yazbek N; Lakkis NM
Catheter Cardiovasc Interv; 2004 Jun; 62(2):193-7. PubMed ID: 15170709
[TBL] [Abstract][Full Text] [Related]
7. Effects of persistent platelet reactivity despite aspirin therapy on cardiac troponin I and creatine kinase-MB levels after elective percutaneous coronary interventions.
Gulmez O; Yildirir A; Kaynar G; Konas D; Aydinalp A; Ertan C; Ozin B; Muderrisoglu H
J Thromb Thrombolysis; 2008 Jun; 25(3):239-46. PubMed ID: 17574519
[TBL] [Abstract][Full Text] [Related]
8. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
[TBL] [Abstract][Full Text] [Related]
9. Frequency and long-term impact of myonecrosis after coronary stenting.
Brener SJ; Ellis SG; Schneider J; Topol EJ
Eur Heart J; 2002 Jun; 23(11):869-76. PubMed ID: 12042008
[TBL] [Abstract][Full Text] [Related]
10. Impact of final activated clotting time after transradial coronary stenting with maximal antiplatelet therapy.
Bertrand OF; Rodés-Cabau J; Rinfret S; Larose E; Bagur R; Proulx G; Gleeton O; Costerousse O; De Larochellière R; Roy L
Am J Cardiol; 2009 Nov; 104(9):1235-40. PubMed ID: 19840568
[TBL] [Abstract][Full Text] [Related]
11. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.
Lev EI; Patel RT; Maresh KJ; Guthikonda S; Granada J; DeLao T; Bray PF; Kleiman NS
J Am Coll Cardiol; 2006 Jan; 47(1):27-33. PubMed ID: 16386660
[TBL] [Abstract][Full Text] [Related]
12. Predictors of periprocedural creatine kinase-myocardial band elevation complicating elective percutaneous coronary intervention.
Cai Q; Skelding KA; Armstrong AT; Desai D; Wood GC; Blankenship JC
Am J Cardiol; 2007 Mar; 99(5):616-20. PubMed ID: 17317359
[TBL] [Abstract][Full Text] [Related]
13. Dose-related effect of aspirin on laboratory-defined platelet aggregation and clinical outcome after coronary stenting.
Kojuri J; Mahmoody Y; Zangbar Sabegh B; Jannati M; Mahboodi A; Khalili A
Cardiovasc Ther; 2010 Jun; 28(3):147-52. PubMed ID: 20557313
[TBL] [Abstract][Full Text] [Related]
14. Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction.
Briguori C; Colombo A; Airoldi F; Violante A; Focaccio A; Balestrieri P; Paolo Elia P; Golia B; Lepore S; Riviezzo G; Scarpato P; Librera M; Bonizzoni E; Ricciardelli B
Eur Heart J; 2004 Oct; 25(20):1822-8. PubMed ID: 15474697
[TBL] [Abstract][Full Text] [Related]
15. Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention.
Mangiacapra F; Barbato E; Patti G; Gatto L; Vizzi V; Ricottini E; D'Ambrosio A; Wijns W; Di Sciascio G
JACC Cardiovasc Interv; 2010 Mar; 3(3):318-23. PubMed ID: 20298992
[TBL] [Abstract][Full Text] [Related]
16. Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention.
Andron M; Stables RH; Egred M; Alahmar AE; Shaw MA; Roberts E; Albouaini K; Grayson AD; Perry RA; Palmer ND
J Invasive Cardiol; 2008 Mar; 20(3):108-12. PubMed ID: 18316825
[TBL] [Abstract][Full Text] [Related]
17. Impact of periprocedural myonecrosis on clinical events after implantation of drug-eluting stents.
Jang JS; Hong MK; Park DW; Lee SW; Kim YH; Lee CW; Kim JJ; Park SW; Park SJ
Int J Cardiol; 2008 Oct; 129(3):368-72. PubMed ID: 18035437
[TBL] [Abstract][Full Text] [Related]
18. Procedure-related myonecrosis after bare and drug-eluting stent implantation.
Lee CH; Tse HF; Tai BC; Chen Z; Chan MY; Tan HC
Asian Cardiovasc Thorac Ann; 2010 Jun; 18(3):272-8. PubMed ID: 20519297
[TBL] [Abstract][Full Text] [Related]
19. Assessment of echo-attenuated plaque by optical coherence tomography and its impact on post-procedural creatine kinase-myocardial band elevation in elective stent implantation.
Lee T; Kakuta T; Yonetsu T; Takahashi K; Yamamoto G; Iesaka Y; Fujiwara H; Isobe M
JACC Cardiovasc Interv; 2011 May; 4(5):483-91. PubMed ID: 21596319
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of clopidogrel unresponsiveness during elective coronary stenting: experience with the point-of-care platelet function assay-100 C/ADP.
Moerenhout CM; Claeys MJ; Haine S; Miljoen H; Bosmans JM; Vertessen F; Kluppels K; Van der Planken M; Vrints CJ
Am Heart J; 2010 Mar; 159(3):434-8. PubMed ID: 20211306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
